New Online Tool Available to Help Health Care Providers Identify a Hard to Diagnose Breast Cancer

A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world’s leading breast cancer organization. This tool will help health care providers recognize and effectively diagnose a rare and aggressive breast cancer, inflammatory breast cancer.

Read more ...

AI and Machine Learning can Successfully Diagnose Polycystic Ovary Syndrome

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and 45, according to a new study by the National Institutes of Health. Researchers systematically reviewed published scientific studies that used AI/ML to analyze data to diagnose and classify PCOS and found that AI/ML based programs were able to successfully detect PCOS.

Read more ...

AI may Outperform Most Humans at Creative Thinking Task

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects (an example of divergent thinking), suggests a study published in Scientific Reports. However, the human participants with the highest scores still outperformed the best chatbot responses.

Read more ...

ChatGPT Performs as Well as Doctors for Suggesting the Most Likely Diagnoses in the Emergency Medicine Department

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be presented at the European Emergency Medicine Congress.

Researchers say a lot more work is needed, but their findings suggest the technology could one day support doctors working in emergency medicine, potentially leading to shorter waiting times for patients.

Read more ...

Smartphone Technology Expected to Advance Assessment of Neurological Soft Signs in Schizophrenia

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased sensory integration (trouble receiving and responding to information transmitted to the brain through the senses) and difficulties with balance, rapid successive movements, and right–left orientation.

Read more ...

More Cases of Breast Cancer Detected with the Help of AI

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital Health. The researchers say that AI is now ready to be implemented in breast cancer screening.

For over 30 years, screening mammography has been an important key in reducing breast cancer mortality rates.

Read more ...

MEDICA 2023 + COMPAMED 2023: "Where Healthcare is Going" - the Leading Motif is Reflected in a Wide Variety of Formats

13 - 16 November 2023, Düsseldorf, Germany.
The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading trade fairs for the medical technology industry and related suppliers could hardly be more exciting. The prices for energy, raw materials, services and many goods are rising. At the same time, health care budgets especially in the publicly financed health sectors of many countries continue to be strongly limited.

Read more ...

Siemens Healthineers Expands Production Site in Rudolstadt, Germany and Creates New Jobs

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators that will be used as radiation sources for Varian's cancer therapy devices. Varian has been a Siemens Healthineers company since 2021.

Read more ...

Online AI-Based Test for Parkinson's Disease Severity Shows Promising Results

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study in npj Digital Medicine describes the new tool, which has users tap their fingers 10 times in front of a webcam to assess motor performance on a scale of 0-4.

Read more ...

AI Performs Comparably to Human Readers of Mammograms

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were published in Radiology, a journal of the Radiological Society of North America (RSNA).

Mammographic screening does not detect every breast cancer. False-positive interpretations can result in women without cancer undergoing unnecessary imaging and biopsy.

Read more ...